225 related articles for article (PubMed ID: 28585762)
1. Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients.
Zhao R; Sun F; Bei X; Wang X; Zhu Y; Jiang C; Zhao F; Han B; Xia S
Prostate; 2017 Jul; 77(10):1107-1117. PubMed ID: 28585762
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of long noncoding RNA FALEC predicts poor prognosis and promotes melanoma cell proliferation through epigenetically silencing p21.
Ni N; Song H; Wang X; Xu X; Jiang Y; Sun J
Biomed Pharmacother; 2017 Dec; 96():1371-1379. PubMed ID: 29196104
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
[TBL] [Abstract][Full Text] [Related]
4. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
[TBL] [Abstract][Full Text] [Related]
5. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
6. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
7. FALEC exerts oncogenic properties to regulate cell proliferation and cell-cycle in endometrial cancer.
Zheng QH; Shi L; Li HL
Biomed Pharmacother; 2019 Oct; 118():109212. PubMed ID: 31387003
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
11. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
12. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
13. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
17. Focally amplified long non-coding RNA in epithelial cancer as a potential biomarker and therapeutic target.
Hobani YH
Biomark Med; 2021 Dec; 15(18):1797-1808. PubMed ID: 34821156
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA FALEC inhibits proliferation and metastasis of tongue squamous cell carcinoma by epigenetically silencing ECM1 through EZH2.
Jia B; Xie T; Qiu X; Sun X; Chen J; Huang Z; Zheng X; Wang Z; Zhao J
Aging (Albany NY); 2019 Jul; 11(14):4990-5007. PubMed ID: 31335317
[TBL] [Abstract][Full Text] [Related]
19. SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis.
Yi C; Wan X; Zhang Y; Fu F; Zhao C; Qin R; Wu H; Li Y; Huang Y
Int J Biochem Cell Biol; 2018 Sep; 102():138-150. PubMed ID: 30053504
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of lncRNA FALEC indicates prognosis and diagnosis values in cervical cancer.
Naizhaer G; Kuerban A; Meilipa ; Kuerban R; Zhou P
Pathol Res Pract; 2019 Aug; 215(8):152495. PubMed ID: 31248657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
